Viewing Study NCT03212469


Ignite Creation Date: 2025-12-24 @ 11:07 PM
Ignite Modification Date: 2026-05-30 @ 7:14 PM
Study NCT ID: NCT03212469
Status: COMPLETED
Last Update Posted: 2025-05-08
First Post: 2017-01-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Squamous Cell Carcinoma View
None Lung Cancer View
None Oesophageal Cancer View
Keywords: